Zobair Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD

Dr. Zobair M. Younossi is the President of Inova Medicine as well as Professor and Chairman of the Department of Medicine at Inova Fairfax Medical Campus. Dr. Younossi earned his medical degree from the University of Rochester School of Medicine and Dentistry (Alpha Omega Alpha 1989) in Rochester, NY. He then completed his residency in internal medicine with a fellowship in gastroenterology and hepatology at Scripps Clinic and Research Foundation in La Jolla, CA, while earning his master of public health degree with multiple honors from San Diego State University School of Public Health. He served as Staff Hepatologist and Senior Researcher at the Cleveland Clinic Foundation before establishing the Center for Liver Diseases at Inova Fairfax Hospital, which is now renowned for research related to outcomes in liver disease and clinical, health services and translational research in nonalcoholic fatty liver disease (NAFLD). He has served as Vice President and Chairman of Research for Inova Health System. He also currently serves as the President and Chairman of the Chronic Liver Disease Foundation’s board of trustees and has been a board member for Inova Health System Foundation since 2011. He was appointed by Governors Kaine and McDonnell of Virginia to the board of directors of the Virginia Biotechnology Research Partnership Authority. He also served on the board of directors of the Virginia Tobacco and Health Research Repository, American Heart Association, mid-Atlantic affiliate and the board of the American College of Gastroenterology’s Institute for Clinical Research and Education. Finally, he has served on multiple committees for the American Association for the Study of Liver Diseases, the American College of Gastroenterology, the American Gastrointestinal Association and George Mason University as well as numerous committees at Inova Fairfax Medical Campus and Inova Health System. Over the past three decades, Dr. Younossi has pioneered research in NAFLD and has been a leader in the field of patient-reported outcomes (PROs), economic assessment and outcomes research in liver disease. He leads several international efforts related to NAFLD and PROs in liver disease though global collaborations, including the Chair of Global Nonalcoholic Steatohepatitis (NASH) Council and the Global Liver and NASH Registries. Dr. Younossi has authored more than 600 articles, 3 books, 6 journal supplements, more than 25 book chapters and more than 1,000 abstracts. He has presented at international scientific meetings and has an H-index of 100. He is sought-after speaker and has provided more than 470 faculty lectures at national and international meetings. Dr. Younossi has also served as the Co-Editor of Liver International, the Associate Editor of the Journal of Hepatology and has been a member of the editorial boards of a number of important medical journals. He has represented the American Association of Liver Disease and the American Gastroenterological Association at different congressional meetings.